1581 |
RILAST 500 |
RITUXIMAB (R-DNA ORIGIN) 500 MG/ 50 ML |
SOLUTION FOR INJECTION |
VIAL |
NON HODGKIN'S LYMPHOMA, PATIENTS WITH DIAGNOSED CHRONIC LYMPHOCYTIC LEUKEMIA, RHEUMATOID ARTHRITIS, GRANULOMATOSIS WITH POLYANGIITIS AND MICROSCOPIC POLYANGITIS |
NULL |
LAO NIYOM PHARMA SOLE CO.,LTD |
HETERO BIOPHARMA LIMITED |
INDIA |
CERTIFICATE RELEASED |
12 I 5366/22 |
30-DEC-2022 |
29-DEC-2025 |
View |
1582 |
TAFNAT |
TENOFOVIR ALAFENAMIDE FUMARATE 28.05 MG EQ.TO TENOFOVIR ALAFENAMIDE 25 MG |
TABLET |
BOTTLE |
FOR THE TREATMENT OF CHRONIC HEPATITIS B IN ADULTS AND ADOLESCENTS(AGED 12 YEARS AND OLDER WITH BODY WEIGHT AT LEAST 35 KG |
NULL |
LAO NIYOM PHARMA SOLE CO.,LTD |
NATCO PHARMA LIMITED |
INDIA |
CERTIFICATE RELEASED |
02 I 5058/21 |
25-SEP-2024 |
24-SEP-2029 |
View |
1583 |
ALIALOH3 |
ALUMINIUM HYDROXIDE 500 MG |
TABLET |
BLISTERPACK |
TO RELIEVE STOMACH PAIN, HEARTBURN AND ACID REGURGITATION CAUSED BY EXCESSIVE GASTRIC ACID |
NULL |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS |
CERTIFICATE RELEASED |
04 L 1327/25 |
07-APR-2025 |
06-APR-2030 |
View |
1584 |
ALIASSIMINI |
ASCIMINIB HYDROCHLORIDE 40 MG |
TABLET |
BOTTLE |
PHILADELPHIA CHROMOSOME POSITIVE MYELOID LEUKEMIA (PH+CML) IN CHRONIC PHASE, PREVIOUSLY TREATED WITH TWO OR MORE TYROSINE KINASE INHIBITOR |
NULL |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS |
CERTIFICATE RELEASED |
10 L 1221/24 |
31-OCT-2024 |
30-OCT-2029 |
View |
1585 |
ALIBERBE |
BERBERINE HYDROCHLORIDE 50 MG |
TABLET |
BLISTERPACK |
INTESTINAL INFECTION SUCH AS GASTRO ENTERITIS , DIARRHEA |
NULL |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS |
CERTIFICATE RELEASED |
07 L 1132/24 |
12-JUL-2024 |
11-JUL-2027 |
View |
1586 |
ALIBETEZIN |
DAPAGLIFLOZIN 10 MG |
TABLET |
BLISTERPACK |
AS AN ADJUNCT TO DIET AND EXCERCISE TO IMPROVE GLYCEMIC CONTROL IN ADULTS WITH TYPE 2 DIABETES, TO REDUCE THE RISK OF HOSPITALIZATION FOR HEART FAILURE IN ADULT WITH TYPE 2 DIABETES MELLITUS AND EITHER ESTABLISHED CARDIOVASCULAR DISEASE OR MULTIPLE CARDIOVASCULAR RISK FACTOR |
NULL |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS |
CERTIFICATE RELEASED |
08 L 1177/24 |
28-AUG-2024 |
27-AUG-2027 |
View |
1587 |
ALIBISOLVON |
BROMHEXINE HYDROCHLORIDE 8MG |
TABLET |
BLISTERPACK |
FOR CHRONIC BRONCHITIS, ASTHMA CAUSED BY STICKY SPUTUM NOT EASY TO COUGH UP PATIENTS |
NULL |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS |
CERTIFICATE RELEASED |
12 L 1049/23 |
15-JAN-2024 |
14-JAN-2027 |
View |
1588 |
ALICAPASE |
CAPIVASERTIB 20 MG |
TABLET |
BOTTLE |
FOR THE TREATMENT OF ADULT PATIENTS WITH HORMONE RECEPTOR-POSITIVE, HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-NEGATIVE, LOCALLY ADVANCED OR METASTATIC BREAST CANCER WITH ONE OR MORE PIK3CA/AKT1/PTEN-ALTERATIONS |
NULL |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS |
CERTIFICATE RELEASED |
07 L 1133/24 |
12-JUL-2024 |
11-JUL-2027 |
View |
1589 |
ALICETIZINE |
CETIRIZINE HYDROCHLORIDE 10 MG |
TABLET |
BLISTERPACK |
SYMPTOMATIC TREATMENT OF SEASONAL RHINITIS, PERENNIAL ALLERGIC RHINITIS, ALLERGIC CONJUNCTIVITIS AND ITCHING AND URTICARIA CAUSED BY ALLERGIES |
NULL |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS |
CERTIFICATE RELEASED |
07 L 1151/24 |
2024-08-07 |
2027-08-06 |
View |
1590 |
ALICIM |
CIMETIDINE 400 MG |
FILM COATED TABLET |
BLISTERPACK |
TO TREAT DUODENAL ULCER, GASTRIC ULCER, REFLUX ESOPHAGITIS, UPPER GASTROINTESTINAL BLEEDING, STRESS ULCER AND ZOLLINGER-ELLISON SYNDROME |
NULL |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS |
CERTIFICATE RELEASED |
07 L 1153/24 |
07-AUG-2024 |
06-AUG-2027 |
View |